A GROUND-BREAKING clinical drug trial for Motor Neurone Disease (MND) has been launched thanks to a £1.5 million investment.
Hundreds of people living with motor neurone disease are now being invited to take part in one of the UK’s most comprehensive clinical trials in a generation.
Currently, over 400 people in Scotland are living with MND and this trial will be open to almost every person in Scotland with the illness.
The platform, MND-SMART, is a UK-wide trial which aims to find treatments that can slow, stop or reverse progression of the terminal disease.
While typical clinical trials focus on a single drug, MND-SMART will allow more than one treatment to be tested at a time, giving patients a higher chance of receiving an active treatment, rather than the placebo.
MND Scotland committed to bringing more MND trials to Scotland in 2020, and by investing £1.5 million this pioneering research is now taking place. This investment accounts for more than half of the charity’s annual turnover, highlighting the importance of the charity’s mission to find a cure.
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules here